Medicine & Life Sciences
Systematic Reviews
100%
Cost-Benefit Analysis
82%
Stroke
52%
National Institutes of Health (U.S.)
40%
Meta-Analysis
38%
Randomized Controlled Trials
35%
Gallstones
32%
Physical Fitness
28%
Delivery of Health Care
27%
Costs and Cost Analysis
24%
Stress Urinary Incontinence
23%
Quality-Adjusted Life Years
22%
Conservative Treatment
22%
Network Meta-Analysis
20%
MEDLINE
19%
Laparoscopic Cholecystectomy
19%
Confidence Intervals
18%
axicabtagene ciloleucel
18%
Suburethral Slings
18%
Transient Ischemic Attack
17%
Therapeutics
17%
Inguinal Hernia
17%
Uncertainty
16%
Databases
16%
Cholecystectomy
15%
Observation
15%
Testosterone
14%
Acute Kidney Injury
13%
Hereditary Angioedemas
13%
Interstitial Cystitis
13%
Pain
13%
Cholecystitis
12%
Prostatic Neoplasms
11%
Vitamin K
11%
Quality of Life
11%
Status Epilepticus
11%
relugolix
11%
lanadelumab
10%
Secondary Prevention
10%
Publications
10%
darolutamide
9%
Psoriasis
9%
Walking
9%
Computed Tomography Angiography
9%
Data Analysis
9%
Equipment and Supplies
9%
Chronic Pain
9%
fostamatinib
9%
7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
9%
teduglutide
9%
Social Sciences
costs
30%
evaluation
21%
economics
20%
life years
14%
surgery
14%
cancer
13%
management
12%
aggregate data
12%
chronic illness
10%
evidence
10%
health
9%
mortality
9%
uncertainty
9%
pain
8%
confidence
8%
technology assessment
7%
Dental Services
6%
trend
6%
current management
5%
nutrition situation
5%
stroke
5%
surveillance
5%
seizure
5%
quality of life
5%